The regulation of muscle mass by endogenous glucocorticoids

被引:181
|
作者
Braun, Theodore P. [1 ,2 ]
Marks, Daniel L. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
加拿大健康研究院;
关键词
glucococorticoids; muscle; skeletal; HPA-axis; cachexia; catabolism; wasting; protein synthesis; 1 NULL MICE; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; PROTEIN-DEGRADATION; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; CANCER CACHEXIA; ATROPHY INVOLVE;
D O I
10.3389/fphys.2015.00012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiguitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Calcineurin: A poorly understood regulator of muscle mass
    Hudson, Matthew B.
    Price, S. Russ
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (10) : 2173 - 2178
  • [2] Leptin mediates the regulation of muscle mass and strength by adipose tissue
    Collins, Kelsey H.
    Gui, Chang
    Ely, Erica, V
    Lenz, Kristin L.
    Harris, Charles A.
    Guilak, Farshid
    Meyer, Gretchen A.
    JOURNAL OF PHYSIOLOGY-LONDON, 2022, 600 (16): : 3795 - 3817
  • [3] Molecular regulation of skeletal muscle mass
    Russell, Aaron P.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (03) : 378 - 384
  • [4] Glucocorticoids and Skeletal Muscle
    Bodine, Sue C.
    Furlow, J. David
    GLUCOCORTICOID SIGNALING: FROM MOLECULES TO MICE TO MAN, 2015, 872 : 145 - 176
  • [5] Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice
    Hu, Zhaoyong
    Wang, Huiling
    Lee, In Hee
    Du, Jie
    Mitch, William E.
    JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) : 3059 - 3069
  • [6] Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
    Baehr, Leslie M.
    Furlow, J. David
    Bodine, Sue C.
    JOURNAL OF PHYSIOLOGY-LONDON, 2011, 589 (19): : 4759 - 4776
  • [7] Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3
    Lin, Ligen
    Chen, Keyun
    Khalek, Waed Abdel
    Ward, Jack Lee, III
    Yang, Henry
    Chabi, Beatrice
    Wrutniak-Cabello, Chantal
    Tong, Qiang
    PLOS ONE, 2014, 9 (01):
  • [8] Growth hormone secretagogue receptor-1a mediates ghrelin's effects on attenuating tumour-induced loss of muscle strength but not muscle mass
    Liu, Haiming
    Zang, Pu
    Lee, Ian
    Anderson, Barbara
    Christiani, Anthony
    Strait-Bodey, Lena
    Breckheimer, Beatrice A.
    Storie, Mackenzie
    Tewnion, Alison
    Krumm, Kora
    Li, Theresa
    Irwin, Brynn
    Garcia, Jose M.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (05) : 1280 - 1295
  • [9] mTORC1 and the regulation of skeletal muscle anabolism and mass
    Adegoke, Olasunkanmi A. J.
    Abdullahi, Abdikarim
    Tavajohi-Fini, Pegah
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2012, 37 (03) : 395 - 406
  • [10] Regulation of Muscle Mass by Follistatin and Activins
    Lee, Se-Jin
    Lee, Yun-Sil
    Zimmers, Teresa A.
    Soleimani, Arshia
    Matzuk, Martin M.
    Tsuchida, Kunihiro
    Cohn, Ronald D.
    Barton, Elisabeth R.
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (10) : 1998 - 2008